Please ensure Javascript is enabled for purposes of website accessibility
Doctors Try CRISPR Gene Editing for Cancer, a 1st in the US
gvw_ap_news
By Associated Press
Published 5 years ago on
November 6, 2019

Share

The first attempt in the United States to use a gene editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it’s too soon to know if it will improve survival, doctors reported Wednesday.

“It’s the most complicated genetic, cellular engineering that’s been attempted so far. This is proof that we can safely do gene editing of these cells.” — Dr. Edward Stadtmauer of the University of Pennsylvania in Philadelphia
The doctors were able to take immune system cells from the patients’ blood and alter them genetically to help them recognize and fight cancer, with minimal and manageable side effects.
The treatment deletes three genes that might have been hindering these cells’ ability to attack the disease, and adds a new, fourth feature to help them do the job.
“It’s the most complicated genetic, cellular engineering that’s been attempted so far,” said the study leader, Dr. Edward Stadtmauer of the University of Pennsylvania in Philadelphia. “This is proof that we can safely do gene editing of these cells.”
After two to three months, one patient’s cancer continued to worsen and another was stable. The third patient was treated too recently to know how she’ll fare. The plan is to treat 15 more patients and assess safety and how well it works.

Chinese Scientists Reportedly Have Tried This for Cancer Patients

“It’s very early, but I’m incredibly encouraged by this,” said one independent expert, Dr. Aaron Gerds, a Cleveland Clinic cancer specialist.

This study is not aimed at changing DNA within a person’s body. Instead it seeks to remove, alter and give back to the patient cells that are super-powered to fight their cancer — a form of immunotherapy.
Other cell therapies for some blood cancers “have been a huge hit, taking diseases that are uncurable and curing them,” and the gene editing may give a way to improve on those, he said.
Gene editing is a way to permanently change DNA to attack the root causes of a disease. CRISPR is a tool to cut DNA at a specific spot. It’s long been used in the lab and is being tried for other diseases.
This study is not aimed at changing DNA within a person’s body. Instead it seeks to remove, alter and give back to the patient cells that are super-powered to fight their cancer — a form of immunotherapy.
Chinese scientists reportedly have tried this for cancer patients, but this is the first such study outside that country. It’s so novel that it took more than two years to get approval from U.S. government regulators to try it.
The early results were released by the American Society of Hematology; details will be given at its annual conference in December.

So Far, the Cells Have Survived and Have Been Multiplying as Intended

The study is sponsored by the University of Pennsylvania, the Parker Institute for Cancer Immunotherapy in San Francisco, and a biotech company, Tmunity Therapeutics. Several study leaders and the university have a financial stake in the company and may benefit from patents and licenses on the technology.
Two of the patients have multiple myeloma, a blood cancer, and the third has a sarcoma, cancer that forms in connective or soft tissue. All had failed multiple standard treatments and were out of good options.
Their blood was filtered to remove immune system soldiers called T cells, which were modified in the lab and then returned to the patients through an IV. It’s intended as a one-time treatment. The cells should multiply into an army within the body and act as a living drug.
So far, the cells have survived and have been multiplying as intended, Stadtmauer said.
“This is a brand new therapy” so not it’s not clear how soon any anti-cancer effects will be seen. Following these patients longer, and testing more of them, will tell, he said.

DON'T MISS

How About an Honest Conversation About the Range of Light Monument Proposal?

DON'T MISS

UConn Coach Geno Auriemma Breaks NCAA Wins Record With 1,217th Victory

DON'T MISS

Fresno Doctors Will Pay $2.4 Million to Settle Kickback Allegations, DOJ Says

DON'T MISS

Warriors Guard De’Anthony Melton to Undergo Season-Ending Knee Surgery

DON'T MISS

Massive Ground Beef Recall Affects Restaurants Nationwide, USDA Warns

DON'T MISS

Chris Stapleton Wins 4 CMA Awards, but Morgan Wallen Is Entertainer of the Year

DON'T MISS

These Fresno Schools Are Unsafe and in Bad Condition. And No One Is Complaining

DON'T MISS

Putin Says Russia Has Tested a New Intermediate Range Missile in a Strike on Ukraine

DON'T MISS

SEC Chair Gary Gensler, Who Led US Crackdown on Cryptocurrencies, to Step Down

DON'T MISS

Is Fresno Mobile Home Park Controversy Over? Tenants Applaud Federal Judge’s Ruling

UP NEXT

Bomb Cyclone Kills 1 and Knocks Out Power to Over Half a Million Homes Across the Northwest US

UP NEXT

Volunteers Came Back to Nonprofits in 2023, After the Pandemic Tanked Participation

UP NEXT

New Study: Proposed Trump Tariffs Could Cost US Consumers $78 Billion a Year

UP NEXT

Riders Stuck in Midair for Over 2 Hours on Knott’s Berry Farm Ride

UP NEXT

Shouting Racial Slurs, Neo-Nazi Marchers Shock Ohio’s Capital

UP NEXT

More Logging Is Proposed to Help Curb Wildfires in the US Pacific Northwest

UP NEXT

Scientists Fear What’s Next for Public Health if RFK Jr. Is Allowed To ‘Go Wild’

UP NEXT

Warren Slams Biden Admin for Failing to Hold Israel Accountable on Gaza Aid

UP NEXT

Suicides in the US Military Increased in 2023, Continuing a Long-Term Trend

UP NEXT

New FDA Rules for TV Drug Ads: Simpler Language and No Distractions

Warriors Guard De’Anthony Melton to Undergo Season-Ending Knee Surgery

2 hours ago

Massive Ground Beef Recall Affects Restaurants Nationwide, USDA Warns

2 hours ago

Chris Stapleton Wins 4 CMA Awards, but Morgan Wallen Is Entertainer of the Year

2 hours ago

These Fresno Schools Are Unsafe and in Bad Condition. And No One Is Complaining

2 hours ago

Putin Says Russia Has Tested a New Intermediate Range Missile in a Strike on Ukraine

2 hours ago

SEC Chair Gary Gensler, Who Led US Crackdown on Cryptocurrencies, to Step Down

2 hours ago

Is Fresno Mobile Home Park Controversy Over? Tenants Applaud Federal Judge’s Ruling

3 hours ago

Wiggins, Curry Power Warriors to Dominant Win Over Hawks

3 hours ago

Sale and Skubal Claim Cy Young Awards After Historic Pitching Triple Crown Seasons

3 hours ago

What Will Happen to CNBC and MSNBC When They No Longer Have a Corporate Connection to NBC News?

3 hours ago

How About an Honest Conversation About the Range of Light Monument Proposal?

It sometimes seems that we have lost the ability to truly communicate with one another. It is not so much what we say to one another, but ho...

59 minutes ago

59 minutes ago

How About an Honest Conversation About the Range of Light Monument Proposal?

2 hours ago

UConn Coach Geno Auriemma Breaks NCAA Wins Record With 1,217th Victory

2 hours ago

Fresno Doctors Will Pay $2.4 Million to Settle Kickback Allegations, DOJ Says

2 hours ago

Warriors Guard De’Anthony Melton to Undergo Season-Ending Knee Surgery

2 hours ago

Massive Ground Beef Recall Affects Restaurants Nationwide, USDA Warns

2 hours ago

Chris Stapleton Wins 4 CMA Awards, but Morgan Wallen Is Entertainer of the Year

2 hours ago

These Fresno Schools Are Unsafe and in Bad Condition. And No One Is Complaining

2 hours ago

Putin Says Russia Has Tested a New Intermediate Range Missile in a Strike on Ukraine

Help continue the work that gets you the news that matters most.

Search

Send this to a friend